12 January 2017 EMA/382258/2015 Human Medicines Evaluation Division

List of nationally authorised medicinal products

Active substance(s): latanoprost (except for products with paediatric indication) Procedure No.: PSUSA/00001832/201604

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged.

Product full name (in authorisation country)

MRP/DCP Authorisation number

Arulatan

UK/H/2391/001

National Authorisation Number 74870.00.00

Arulatan 50 micrograme/ml picături oftalmice, soluţie Arulatan 50 micrograme/ml picături oftalmice, soluţie Arulatan 50 micrograme/ml picături oftalmice, soluţie Arulatan 50 microgrammi/ml collirio, soluzione Arulatan 50 microgrammi/ml collirio, soluzione Arulatan 50 microgrammi/ml collirio, soluzione Arulatan 50 microgramos/ml, colirio en solución Arulatan 50 mikrogrami/ml, acu pilieni, škidums Arulatan 50 mikrogramov/ml, očná roztoková instilácia Arulatan 50 mikrogramu/ml, ocní kapky, roztok Arulatan 50 μικρογραμμάρια/ml, οφθαλμικές σταγόνες, διάλυμα Arulatan 50micrograms/ml eye drops,solution Arulatan, 50 mikrogrammi/ml, silmatilgad, lahus Arulatan® 50 Mikrogramm/ml Augentropfen Droplatan 50 microgrammi/ml collirio, soluzione

UK/H/1986/001

3113/2010/02

UK/H/1986/001

3113/2010/03

UK/H/1986/001

3113/2010/01

UK/H/1986/001

040719015/M

UK/H/1986/001

040719027/M

UK/H/1986/001

040719039/M

UK/H/1986/001

72964

UK/H/1986/001

10-0572

UK/H/1986/001

64/0610/10-S

UK/H/1986/001

64/672/10-C

UK/H/1986/001

64453/21.12.15

UK/H/1986/001

20100683

UK/H/1986/001

704110

UK/H/1986/001

1-29743

IT/H/0401/001

039874019

Droplatan 50 microgrammi/ml collirio, soluzione

IT/H/0401/001

039874021

List of nationally authorised medicinal products EMA/382258/2015

MAH of product in the member state DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH BAUSCH & LOMB GMBH AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A.

Member State where product is authorised DE RO RO RO IT IT IT ES LV SK CZ GR BG EE AT IT IT

Page 2/8

Product full name (in authorisation country)

MRP/DCP Authorisation number

Droplatan 50 microgrammi/ml collirio, soluzione

IT/H/0401/001

National Authorisation Number 039874033

Eylasol 50 microgram/ml, oogdruppels, oplossing. Lanotan 50 mikrogramm/ml oldatos szemcsepp LATANOGAN 0.005% w/v Οφθαλμικές σταγόνες, διάλυμα Latan-Ophtal

NL/H/1406/001

RVG 102637

UK/H/1986/001

OGYI-T-21504/01

not available

77800

UK/H/1986/001

74868.00.00

Latanoprost 0.005% w/v eye drops solution Latanoprost 50 micrograms/ml, eye drops, solution Latanoprost Apotex 0,005% oční kapky, roztok Latanoprost Apotex 0.005% w/v Eye Drops, Solution Latanoprost Apotex 50 microgram/ml, oogdruppels, oplossing Latanoprost Apotex 50 microgramos / ml colirio en solución Latanoprost Apotex® 0,005% g/v, oogdruppels, oplossing Latanoprost Apotex® 0,005% m/v collyre en solution Latanoprost Bausch & Lomb, 50 micrograms/ml, eye drops, solution LATANOPROST CINFA 50 MICROGRAMOS/ML COLIRIO EN SOLUCIÓN

UK/H/2707/001

PL 17918/0014

UK/H/2390/001

PL 13757/0004

UK/H/2236/001

MAH of product in the member state AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. RATIOPHARM NEDERLAND B.V

Member State where product is authorised IT NL

DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH ZWITTER PHARMACEUTICALS ΕΠΕ

HU

DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH TUBILUX PHARMA S.P.A.

DE

UK

64/941/10-C

DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH APOTEX EUROPE B.V.

UK/H/2236/001

PL 27583/0098

APOTEX EUROPE B.V.

UK

UK/H/2236/001

RVG 105029

APOTEX EUROPE B.V.

NL

UK/H/2236/001

73.265

APOTEX EUROPE B.V.

ES

UK/H/2236/001

BE386793

APOTEX EUROPE BV

BE

UK/H/2236/001

1175/10120022

APOTEX EUROPE B.V.

LU

UK/H/1986/001

PL 13757/0003

DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH

UK

UK/H/2707/001/DC

73959

LABORATORIOS CINFA, S.A.

ES

List of nationally authorised medicinal products EMA/382258/2015

GR

UK

CZ

Page 3/8

Product full name (in authorisation country)

MRP/DCP Authorisation number

MAH of product in the member state

UK/H/1986/001

National Authorisation Number 5316849

Latanoprost Dr. Gerhard Mann Chem.-pharm. Fabrik 50 microgramas/ml, colírio, solução Latanoprost Dr. Mann Pharma, 50 micrograms/ml, eye drops, solution Latanoprost Qualigen 50 microgramos/ml colirio en solución Latanoprost ratiopharm 50 microgramos/ml colirio en solución Latanoprost ratiopharm Italia 50 microgrammi/ml collirio, soluzione Latanoprost ratiopharm Italia 50 microgrammi/ml collirio, soluzione Latanoprost ratiopharm Italia 50 microgrammi/ml collirio, soluzione Latanoprost Stulln 50 Mikrogramm/ml Augentropfen Latanoprost Tubilux Pharma 0,005% collirio, soluzione Latanoprost Tubilux Pharma 0,005% collirio, soluzione Latanoprost Tubilux Pharma 0,005% collirio, soluzione LATAPRES 50 mikrograma/ml kapi za oko, otopina MONOPOST 50 micrograme/ml, picaturi oftalmice, solutie în recipient unidoza

UK/H/2391/001

PL 13757/0005

DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH

UK

not available

74.843

QUALIGEN, S.L.

ES

NL/H/1406/001

71101

RATIOPHARM ESPAÑA, S.A

ES

NL/H/1406/001

039468020

RATIOPHARM ITALIA S.R.L.

IT

NL/H/1406/001

039468032

RATIOPHARM ITALIA S.R.L.

IT

NL/H/1406/001

039468018

RATIOPHARM ITALIA S.R.L.

IT

not available

75006.00.00

PHARMA STULLN GMBH

DE

UK/H/2707/001

039972017

TUBILUX PHARMA S.P.A.

IT

UK/H/2707/001

039972029

TUBILUX PHARMA S.P.A.

IT

UK/H/2707/001

039972031

TUBILUX PHARMA S.P.A.

IT

not available

UP/I-530-09/1201/190 5346/2013/01

PHARMASWISS ČESKÁ REPUBLIKA S.R.O. LABORATOIRES THEA

HR

FR/H/0499/001

List of nationally authorised medicinal products EMA/382258/2015

DR. GERHARD MANN CHEM.PHARM. FABRIK GMBH

Member State where product is authorised PT

RO

Page 4/8

Product full name (in authorisation country)

MRP/DCP Authorisation number

MAH of product in the member state

FR/H/0499/001

National Authorisation Number 5346/2013/02

LABORATOIRES THEA

Member State where product is authorised RO

MONOPOST 50 micrograme/ml, picături oftalmice, soluţie în recipient unidoză MONOPOST 50 micrograme/ml, picături oftalmice, soluţie în recipient unidoză MONOPOST 50 micrograme/ml, picături oftalmice, soluţie în recipient unidoză MONOPOST 50 micrograms/ml eye drops, solution in singledose container. Monopost 50 Mikrogramm/ml Augentropfen im Einzeldosisbehältnis Monopost 50 mikrogramov/ml kapljice za oko, raztopina v enoodmernem vsebniku Monopost 50 mikrogramov/ml kapljice za oko, raztopina v enoodmernem vsebniku MONOPOST 50 mikrogramov/ml, ocná roztoková instilácia v jednodávkovom obale MONOPOST 50 mikrogramu/ml akiu lašai (tirpalas vienadozeje talpykleje) MONOPOST 50 mikrogramų/ml akių lašai (tirpalas vienadozėje talpyklėje) MONOPOST 50 mikrogramų/ml akių lašai (tirpalas vienadozėje talpyklėje) MONOPOST 50 mikrogramų/ml akių lašai (tirpalas vienadozėje talpyklėje)

FR/H/0499/001

5346/2013/03

LABORATOIRES THEA

RO

FR/H/0499/001

5346/2013/04

LABORATOIRES THEA

RO

FR/H/0499/001

PL 20162/0015

LABORATOIRES THEA

UK

FR/H/0499/001

1-31607

LABORATOIRES THEA

AT

FR/H/0499/001

5363-I-131/13

LABORATOIRES THEA

SI

FR/H/0499/001

5363-I-132/13

LABORATOIRES THEA

SI

FR/H/0499/001

64/0072/13-S

LABORATOIRES THEA

SK

FR/H/0499/001

LT/1/13/3236/001

LABORATOIRES THEA

LT

FR/H/0499/001

LT/1/13/3236/002

LABORATOIRES THEA

LT

FR/H/0499/001

LT/1/13/3236/003

LABORATOIRES THEA

LT

FR/H/0499/001

LT/1/13/3236/004

LABORATOIRES THEA

LT

List of nationally authorised medicinal products EMA/382258/2015

Page 5/8

Product full name (in authorisation country)

MRP/DCP Authorisation number

MAH of product in the member state

FR/H/0499/001

National Authorisation Number 64/003/12-C

LABORATOIRES THEA

Member State where product is authorised CZ

Monopost 50 mikrogramu/ml ocní kapky, roztok v jednodávkovém obalu Monopost Unidose 50 micrograms/ml eye drops, solution in single-dose container Monopro 50 mikrogrammi/ml silmatilgad, lahus üheannuselises pakendis MONOPROST 50 µg/ml νθζαικηθέο ζηαγφλεο, δηάιπκα ζε πεξηέθηε κίαο δφζεο Monoprost 50 microgram/ml, oogdruppels, oplossing in verpakking voor éénmalig gebruik Monoprost 50 microgram/ml, oogdruppels, oplossing in verpakking voor éénmalig gebruik MONOPROST 50 microgramas/ml colírio, solução em recipiente unidose Monoprost 50 microgrammes/ml, collyre en solution en récipient unidose MONOPROST 50 microgrammes/ml, collyre en solution en récipient unidose MONOPROST 50 microgrammes/ml, collyre en solution en récipient unidose MONOPROST 50 microgrammes/ml, collyre en solution en récipient unidose

FR/H/0499/001

PA1107/7/1

LABORATOIRES THEA

IE

FR/H/0499/001

797012

LABORATOIRES THEA

EE

FR/H/0499/001

021947

LABORATOIRES THEA

CY

FR/H/0499/001

BE428635

LABORATOIRES THEA

BE

FR/H/0499/001

RVG 110246

LABORATOIRES THEA

NL

FR/H/0499/001

5552724

LABORATOIRES THEA

PT

FR/H/0499/001

BE428635

LABORATOIRES THEA

BE

FR/H/0499/001

34009 267 379 5 5

LABORATOIRES THEA

FR

FR/H/0499/001

34009 267 380 3 7

LABORATOIRES THEA

FR

FR/H/0499/001

34009 267 382 6 6

LABORATOIRES THEA

FR

List of nationally authorised medicinal products EMA/382258/2015

Page 6/8

Product full name (in authorisation country)

MRP/DCP Authorisation number

MAH of product in the member state

FR/H/0499/001

National Authorisation Number 34009 583 657 1 3

LABORATOIRES THEA

Member State where product is authorised FR

MONOPROST 50 microgrammes/ml, collyre en solution en récipient unidose Monoprost 50 microgrammes/ml, collyre en solution en récipient unidose MONOPROST 50 microgrammi/ml collirio soluzione in contenitore monodose. MONOPROST 50 microgrammi/ml collirio soluzione in contenitore monodose. MONOPROST 50 microgrammi/ml collirio soluzione in contenitore monodose. MONOPROST 50 microgrammi/ml collirio soluzione in contenitore monodose. Monoprost 50 microgramos/ml colirio en solución en envase unidosis. Monoprost 50 mikrog/ml silmätipat, liuos, kertaannospakkaus Monoprost 50 mikrogram/ml øyedråper, oppløsning Monoprost 50 mikrogram/ml, ögondroppar, lösning i endosbehållare Monoprost 50 mikrogrami/ml acu pilieni, škidums, vienreizejas devas traucinš.

FR/H/0499/001

BE428635

LABORATOIRES THEA

LU

FR/H/0499/001

41429010

LABORATOIRES THEA

IT

FR/H/0499/001

41429022

LABORATOIRES THEA

IT

FR/H/0499/001

41429034

LABORATOIRES THEA

IT

FR/H/0499/001

41429046

LABORATOIRES THEA

IT

FR/H/0499/001

76616

LABORATORIOS THEA S.A.

ES

FR/H/0499/001

30049

LABORATOIRES THEA

FI

FR/H/0499/001

11-8494

LABORATOIRES THEA

NO

FR/H/0499/001

46521

LABORATOIRES THEA

SE

FR/H/0499/001

12-0277

LABORATOIRES THEA

LV

List of nationally authorised medicinal products EMA/382258/2015

Page 7/8

Product full name (in authorisation country)

MRP/DCP Authorisation number

MAH of product in the member state

FR/H/0499/001

National Authorisation Number 85424.00.00

LABORATOIRES THEA

Member State where product is authorised DE

MONOPROST 50 Mikrogramm/ml Augentropfen im Einzeldosisbehältnis MONOPROST 50 míkrógrömm/ml augndropar, lausn í stakskammtaíláti MONOPROST 50 κg/ml νθζαικηθέο ζηαγφλεο, δηάιπκα ζε πεξηέθηε κίαο δφζεο. MONOPROST 50 μg/ml οφθαλμικές σταγόνες, διάλυμα σε περιέκτη μίας δόσης. MONOPROST, 50 mikrogramów/ml, krople do oczu, roztwór w pojemniku jednodawkowym Monoprost, øjendråber, opløsning, enkeltdosisbeholder OCUSYNT 50 microgrammi/ml collirio, soluzione VLEPOLIN XELOR 50 microgramos/ml colirio en solución МОНОПРОСТ 50 микрограма/ml капки за очи, разтвор в еднодозов контейнер.

FR/H/0499/001

IS/1/12/106/01

LABORATOIRES THEA

IS

FR/H/0499/001

021947

LABORATOIRES THEA

CY

FR/H/0499/001

23708/22-3-2013

LABORATOIRES THEA

GR

FR/H/0499/001

20654

LABORATOIRES THEA

PL

FR/H/0499/001

49449

LABORATOIRES THEA

DK

not available

038612038

GENETIC SPA

IT

not available not available

85259/12/28-05-2013 73.700

DEMO ABEE TEDEC-MEIJI FARMA, S.A.

GR ES

FR/H/0499/001

20130076

LABORATOIRES THEA

BG

List of nationally authorised medicinal products EMA/382258/2015

Page 8/8

Latanoprost - European Medicines Agency - Europa EU

Jan 12, 2017 - Send a question via our website www.ema.europa.eu/contact. © European ... Product full name. (in authorisation ... not available. 77800.

166KB Sizes 3 Downloads 376 Views

Recommend Documents

latanoprost - European Medicines Agency - Europa EU
May 13, 2016 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ..... Xaloptic Free. NL/H/3193/001.

latanoprost - European Medicines Agency - Europa EU
Nov 30, 2017 - ES. Latanoprost Combix 50 microgramos/ml colirio en solución. NL/H/1948/001. 75.082. LABORATORIOS COMBIX,. S.L.U.. ES. Latanoprost DEMO 50. Mikrogramm/ml. Augentropfen, Lösung. UK/H/5496/001. 91614.00.00. DEMO S.A.. DE. LATANOPROST E

Agenda - European Medicines Agency - Europa EU
Jul 7, 2017 - COMMUNITY MARKETING AUTHORISATIONS AND EXTENSIONS. 2.1. Opinions ... Quality. Rapp: E. Werner .... solutions table with EMA and CVMP responses to the recommendations made by the FishMed Plus. Coalition ...

May 2016 - European Medicines Agency - Europa EU
Jun 22, 2016 - Information Management Division ... This document provides current information related to the volume and evaluation of .... Plasma master file.

Eleclazine - European Medicines Agency - Europa EU
Feb 9, 2017 - Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply).

July 2017 - European Medicines Agency - Europa EU
Jul 5, 2017 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

July 2016 - European Medicines Agency - Europa EU
Jul 4, 2016 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

SME Office - European Medicines Agency - Europa EU
maximises the chances of a successful marketing authorisation. ... marketing authorisation. • inclusion in the public SME ... E-mail [email protected]. Website ...

Agenda - European Medicines Agency - Europa EU
Jun 19, 2017 - and may also vary during the course of the review. ...... ViiV Healthcare UK Limited; Treatment of Human Immunodeficiency Virus ..... adjunctive administration of brivaracetam, Treatment of paediatric patients with partial.

Action plan - European Medicines Agency - Europa EU
5 days ago - Guidelines should include more details on the principles of good information design in which content and layout are ... relevance and importance of the QRD template is also acknowledged in this respect as it is the main tool .... databas

Agenda - European Medicines Agency - Europa EU
Jun 15, 2016 - Agenda - EMA Human Scientific Committees' Working. Parties with Healthcare Professionals' Organisations. (HCPWP) meeting. 15 June 2016, 08:45hrs to 10:30hrs – meeting room: 3E. Chairs: I. Moulon (EMA) and Gonzalo Calvo (HCPWP). 15 Ju

Agenda - European Medicines Agency - Europa EU
Jun 26, 2018 - oxadiazole-3-carboximidamide - EMEA-002072-PIP01-16-M01 . ..... Human alpha-galactosidase A - Orphan - EMEA-001828-PIP01-15-M01 .

Agenda - European Medicines Agency - Europa EU
Jul 16, 2018 - Cladribine, EMA/OD/087/17 Recombinant monoclonal antibody to sialic acid-binding Ig-like lectin 8. 2.2.6. - EMA/OD/098/18. Treatment of ...

SPOR - European Medicines Agency - Europa EU
Feb 7, 2017 - Add an existing Tag to a specific Term . ...... This service creates an email body (text/html) of a user's notification data, a notification is based on.

ATMP - European Medicines Agency - Europa EU
Nov 24, 2017 - E8. 09/08/2017. 10/08/2017. 24/08/2017 17/08/2017 22/08/2017. 24/08/2017. 30/08/2017. 01/09/2017. 04/09/2017. 08/09/2017. 14/09/2017.

Agenda - European Medicines Agency - Europa EU
Feb 9, 2018 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union ... product information. For information: Summary of opinion. 2.2. Oral explanations and list of outstanding issues. •. Product

Agenda - European Medicines Agency - Europa EU
Oct 23, 2017 - Page 2/61. Table of contents. 1. Introduction. 11. 1.1. Welcome and declarations of interest of members, alternates and experts .......... 11. 1.2. Agenda of the meeting on 23-26 October 2017 . ...... different database to study the ri

Evofosfamide - European Medicines Agency - Europa EU
Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply). (possible) lack of ...

Agenda - European Medicines Agency - Europa EU
17 Jan 2018 - Expert meeting on adeno-associated viral vectors, 06 September 2017, EMA, London. CAT: Martina Schüßler-Lenz. Scope: report of the meeting that took place on 6 September 2017. Action: for adoption. 7.6.3. Environmental assessment of g

minoxidil - European Medicines Agency - Europa EU
Jun 14, 2018 - Page 2/26. Product Name (in authorisation country). MRP/DCP Authorisation number. National Authorisation. Number. MAH of product in the.

Influenza vaccine - European Medicines Agency - Europa EU
Oct 26, 2017 - Injektionssuspension in einer Fertigspritze. Influenza-Impfstoff. (Spaltimpfstoff, inaktiviert, in Zellkulturen hergestellt) not available. BE393556. NANOTHERAPEUTICS. BOHUMIL, S.R.O.. BE. Preflucel injektionsvätska, suspension i för

Cyproterone/ethinylestradiol - European Medicines Agency - Europa EU
March 2016 a joint database drug utilisation final study report to the European .... With regards to prescription of CPA/EE for contraceptive management, ...

ganciclovir - European Medicines Agency - Europa EU
Feb 9, 2017 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ... not available. 20010180.

July 2016 - European Medicines Agency - Europa EU
For a list of RSS readers please refer to our RSS guide and follow the instructions ..... PCWP and HCPWP joint meeting: Workshop on social media - Sep 2016.